Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Ribociclib|OTHER: Mono-chemotherapy|OTHER: Endocrine-Therapy
Sponsor: Swiss Group for Clinical Cancer Research
Collaborators: The Belgian Society of Medical Oncology